Survival outcome of intermediate risk neuroblastoma at Children Cancer Hospital Egypt by Hossam Elzomor, Gehad Ahmed, Salma Elmenawi, Naglaa Elkinaai, Amal Refaat, Sonya Soliman, Mai Amr Abdelwahab, Mohamed Saad Zaghloul, Mohamed Fawzy

Subjects: Get full text

A phase II JN-I-10 efficacy study of IDRF-based surgical decisions and stepwise treatment intensification for patients with intermediate-risk neuroblastoma: a study protocol by Tomoko Iehara, Akihiro Yoneda, Atsushi Kikuta, Toshihiro Muraji, Kazuaki Tokiwa, Hideto Takahashi, Satoshi Teramukai, Tetsuya Takimoto, Shigeki Yagyu, Hajime Hosoi, Tatsuro Tajiri, the Japan Children’s Cancer Group Neuroblastoma Committee

Subjects: Get full text

Favorable intermediate risk prostate cancer with biopsy Gleason score of 6 by Jong Jin Oh, Hyungwoo Ahn, Sung Il Hwang, Hak Jong Lee, Gheeyoung Choe, Sangchul Lee, Hakmin Lee, Seok-Soo Byun, Sung Kyu Hong

Subjects: Get full text

Eligibility criteria according to EAU/ESTRO/SIOG guidelines for exclusive iodine-125 brachytherapy for intermediate-risk prostate adenocarcinoma patients: impact on relapse-free su... by Sophie Robin, Sylvie Chabaud, Anne-Agathe Serre, Béatrice Bringeon, Sébastien Clippe, François Rocher, Olivier Desmettre, Gabriel Bringeon, Frédéric Gassa, Pascal Pommier

Subjects: Get full text

High-dose-rate interstitial brachytherapy for accelerated partial breast irradiation – trial results of Azerbaijan National Center of Oncology by Jamil A. Aliyev, Isa H. Isayev, Kamal S. Akbarov, Samir S. Qurbanov, Ruslan R. Huseynov, Nigar S. Aliyeva

Subjects: Get full text

Optional therapeutic management of intermediate-risk pulmonary embolism patients by Nadejda Diaconu, Irina Civirjic, Galina Sorici, Aurel Grosu, Tatiana Cuzor, Sabina Racila-Iatco

Subjects: Get full text

Study of noninduction immunosuppression in intermediate-risk living donor kidney transplantation in rural population of India - A retrospective observational study by Ankit Data, Kshitija G Gadekar, Vajed R Mogal, Abhijeet S More, Sudhir Gajanan Kulkarni

Subjects: Get full text

Direct comparison of low-dose-rate brachytherapy versus radical prostatectomy using the surgical definition of biochemical recurrence for patients with intermediate-risk prostate c... by Hideyasu Tsumura, Nobumichi Tanaka, Tomohiko Oguchi, Takuya Owari, Yasushi Nakai, Isao Asakawa, Kazuyoshi Iijima, Haruaki Kato, Iwao Hashida, Ken-ichi Tabata, Takefumi Satoh, Hiromichi Ishiyama

Subjects: Get full text

The net benefit of thrombolysis in the management of intermediate risk pulmonary embolism: Systematic review and meta‐analysis by Pedro E. Alcedo, Herney Andrés García‐Perdomo, Cristhiam M. Rojas‐Hernandez

Subjects: Get full text

Systemic thrombolysis with newer thrombolytics vs anticoagulation in acute intermediate risk pulmonary embolism: a systematic review and meta-analysis by Don Mathew, Susmitha Seelam, Karandeep Bumrah, Akil Sherif, Utsav Shrestha

Subjects: “…Intermediate risk PE…”
Get full text

The effect of fibrinolytic therapy on 30-day outcome in patients with intermediate risk pulmonary embolism - propensity score-adjusted analysis by Radovanović Nebojša, Radosavljević-Radovanović Mina, Marinković Jelena, Antonijević Nebojša, Dobrić Milan, Mitrović Predrag, Prodanović Maja, Matić Dragan, Lasica Ratko, Savić Lidija

Subjects: Get full text

Is postoperative radioactive iodine associated with a survival advantage among… by Hamed Rasha Hamdy

Subjects: Get full text

Phase II Study of ENZAlutamide Combined With Hypofractionated Radiation Therapy (ENZART) for Localized Intermediate Risk Prostate Cancer by Pedro C. Lara, Juan I. Rodríguez-Melcón, Amalia Palacios-Eito, Antonio Lozano, Asunción Hervás-Morón, Elena Villafranca, Alfonso Gómez-Iturriaga, Gemma Sancho, Xavier Maldonado

Subjects: Get full text

Clinical outcomes of low-dose-rate brachytherapy based radiotherapy for intermediate risk prostate cancer by Keisei Okamoto, Kahori Okuyama, Naoaki Kohno, Takuya Tsugawa

Subjects: Get full text

Aggressive histopathological variants of papillary thyroid carcinoma, diagnostic challenge, and clinical significance—A case series by P K Pravanya, K R Anila, Shaji Thomas, A Sreekumar, K Jayasree

Subjects: Get full text

Lymph Node Metastases Identified at the Post-Ablation 131I SPECT/CT Scan Is a Prognostic Factor of Intermediate-Risk Papillary Thyroid Cancer by Xi Jia, Yuanbo Wang, Lulu Yang, Kun Fan, Runyi Tao, Hui Liu, Xiaobao Yao, Aimin Yang, Guangjian Zhang, Rui Gao

Subjects: Get full text

Active surveillance should not be routinely considered in ISUP grade group 2 prostate cancer by Giorgio Gandaglia, Riccardo Leni, Sophie Plagakis, Armando Stabile, Francesco Montorsi, Alberto Briganti

Subjects: Get full text

Impact of androgen deprivation therapy in patients with unfavorable intermediate-risk prostate cancer receiving brachytherapy-based dose-escalated radiation therapy by Nikhil T. Sebastian, Subir Goyal, Yuan Liu, Vishal Dhere, Ashesh B. Jani, Bruce Hershatter, Pretesh R. Patel, Jay W. Shelton, Sheela Hanasoge, Karen D. Godette, Sagar A. Patel

Subjects: “…unfavorable intermediate-risk…”
Get full text

Clinicopathological and ultrasound features as risk stratification predictors of clinical and pathological nodal status in papillary thyroid carcinoma: a study of 748 patients by Cui Zhang, Baojun Li, Lei Zhang, Fengjiao Chen, Yanhua Zhang, Wen Cheng

Subjects: Get full text

Identifying a molecular profile to predict the risk of recurrence in high‐intermediate risk endometrial cancer by Rebecca C. Arend, Carly B. Scalise, Jhalak Dholakia, Maahum Z. Kamal, Haley B. Thigpen, David Crossman, Warner K. Huh, Charles A. Leath III

Subjects: Get full text